A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

Primary ovarian mucinous tumors can be difficult to distinguish from metastatic gastrointestinal neoplasms by histology alone. The expected immunoprofile of a suspected metastatic lower gastrointestinal tumor is CK7−/CK20+/CDX2+/PAX8−. This study assesses the addition of a novel marker SATB2, to imp...

Full description

Saved in:
Bibliographic Details
Main Authors: Meagher, Nicola S. (Author) , Herpel, Esther (Author) , Sinn, Peter (Author) , Chang-Claude, Jenny (Author)
Format: Article (Journal)
Language:English
Published: 25 June 2019
In: Modern pathology
Year: 2019, Volume: 32, Issue: 12, Pages: 1834-1846
ISSN:1530-0285
DOI:10.1038/s41379-019-0302-0
Online Access:Verlag, Volltext: https://doi.org/10.1038/s41379-019-0302-0
Verlag: https://www.nature.com/articles/s41379-019-0302-0
Get full text
Author Notes:Nicola S. Meagher, Linyuan Wang, Peter F. Rambau, Maria P. Intermaggio, David G. Huntsman, Lynne R. Wilkens, Mona A. El-Bahrawy, Roberta B. Ness, Kunle Odunsi, Helen Steed, Esther Herpel, Michael S. Anglesio, Bonnie Zhang, Neil Lambie, Anthony J. Swerdlow, Jan Lubiński, Robert A. Vierkant, Ellen L. Goode, Usha Menon, Aleksandra Toloczko-Grabarek, Oleg Oszurek, Sanela Bilic, Aline Talhouk, Montserrat García-Closas, Qin Wang, Adeline Tan, Rhonda Farrell, Catherine J. Kennedy, Mercedes Jimenez-Linan, Karin Sundfeldt, John L. Etter, Janusz Menkiszak, Marc T. Goodman, Paul Klonowski, Yee Leung, Stacey J. Winham, Kirsten B. Moysich, Sabine Behrens, Tomasz Kluz, Robert P. Edwards, Jacek Gronwald, Francesmary Modugno, Brenda Y. Hernandez, Christine Chow, Linda E. Kelemen, Gary L. Keeney, Michael E. Carney, Yanina Natanzon, Gregory Robertson, Raghwa Sharma, Simon A. Gayther, Jennifer Alsop, Hugh Luk, Chloe Karpinskyj, Ian Campbell, Peter Sinn, Aleksandra Gentry-Maharaj, Penny Coulson, Jenny Chang-Claude, Mitul Shah, Martin Widschwendter, Katrina Tang, Minouk J. Schoemaker, Jennifer M. Koziak, Linda S. Cook, James D. Brenton, Frances Daley, Björg Kristjansdottir, Constantina Mateoiu, Melissa C. Larson, Paul R. Harnett, Audrey Jung, Anna deFazio, Kylie L. Gorringe, Paul D.P. Pharoah, Parham Minoo, Colin Stewart, Oliver F. Bathe, Xianyong Gui, Paul Cohen, Susan J. Ramus, Martin Köbel

MARC

LEADER 00000caa a2200000 c 4500
001 1688466924
003 DE-627
005 20240404193228.0
007 cr uuu---uuuuu
008 200124s2019 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41379-019-0302-0  |2 doi 
035 |a (DE-627)1688466924 
035 |a (DE-599)KXP1688466924 
035 |a (OCoLC)1341298625 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Meagher, Nicola S.  |e VerfasserIn  |0 (DE-588)120338985X  |0 (DE-627)1688469656  |4 aut 
245 1 2 |a A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases  |c Nicola S. Meagher, Linyuan Wang, Peter F. Rambau, Maria P. Intermaggio, David G. Huntsman, Lynne R. Wilkens, Mona A. El-Bahrawy, Roberta B. Ness, Kunle Odunsi, Helen Steed, Esther Herpel, Michael S. Anglesio, Bonnie Zhang, Neil Lambie, Anthony J. Swerdlow, Jan Lubiński, Robert A. Vierkant, Ellen L. Goode, Usha Menon, Aleksandra Toloczko-Grabarek, Oleg Oszurek, Sanela Bilic, Aline Talhouk, Montserrat García-Closas, Qin Wang, Adeline Tan, Rhonda Farrell, Catherine J. Kennedy, Mercedes Jimenez-Linan, Karin Sundfeldt, John L. Etter, Janusz Menkiszak, Marc T. Goodman, Paul Klonowski, Yee Leung, Stacey J. Winham, Kirsten B. Moysich, Sabine Behrens, Tomasz Kluz, Robert P. Edwards, Jacek Gronwald, Francesmary Modugno, Brenda Y. Hernandez, Christine Chow, Linda E. Kelemen, Gary L. Keeney, Michael E. Carney, Yanina Natanzon, Gregory Robertson, Raghwa Sharma, Simon A. Gayther, Jennifer Alsop, Hugh Luk, Chloe Karpinskyj, Ian Campbell, Peter Sinn, Aleksandra Gentry-Maharaj, Penny Coulson, Jenny Chang-Claude, Mitul Shah, Martin Widschwendter, Katrina Tang, Minouk J. Schoemaker, Jennifer M. Koziak, Linda S. Cook, James D. Brenton, Frances Daley, Björg Kristjansdottir, Constantina Mateoiu, Melissa C. Larson, Paul R. Harnett, Audrey Jung, Anna deFazio, Kylie L. Gorringe, Paul D.P. Pharoah, Parham Minoo, Colin Stewart, Oliver F. Bathe, Xianyong Gui, Paul Cohen, Susan J. Ramus, Martin Köbel 
264 1 |c 25 June 2019 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.01.2020 
520 |a Primary ovarian mucinous tumors can be difficult to distinguish from metastatic gastrointestinal neoplasms by histology alone. The expected immunoprofile of a suspected metastatic lower gastrointestinal tumor is CK7−/CK20+/CDX2+/PAX8−. This study assesses the addition of a novel marker SATB2, to improve the diagnostic algorithm. A test cohort included 155 ovarian mucinous tumors (105 carcinomas and 50 borderline tumors) and 230 primary lower gastrointestinal neoplasms (123 colorectal adenocarcinomas and 107 appendiceal neoplasms). All cases were assessed for SATB2, PAX8 CK7, CK20, and CDX2 expression on tissue microarrays. Expression was scored in a 3-tier system as absent, focal (1-50% of tumor cells) and diffuse ( >50% of tumor cells) and then categorized into either absent/present or nondiffuse/diffuse. SATB2 and PAX8 expression was further evaluated in ovarian tumors from an international cohort of 2876 patients (expansion cohort, including 159 mucinous carcinomas and 46 borderline mucinous tumors). The highest accuracy of an individual marker in distinguishing lower gastrointestinal from ovarian mucinous tumors was CK7 (91.7%, nondiffuse/diffuse cut-off) followed by SATB2 (88.8%, present/absent cut-off). The most effective combination was CK7 and SATB2 with accuracy of 95.3% using the 3-tier interpretation, absent/focal/diffuse. This combination outperformed the standard clinical set of CK7, CK20 and CDX2 (87.5%). Re-evaluation of outlier cases confirmed ovarian origin for all but one case. The accuracy of SATB2 was confirmed in the expansion cohort (91.5%). SATB2 expression was also detected in 15% of ovarian endometrioid carcinoma but less than 5% of other ovarian histotypes. A simple two marker combination of CK7 and SATB2 can distinguish lower gastrointestinal from ovarian primary mucinous tumors with greater than 95% accuracy. PAX8 and CDX2 have value as second-line markers. The utility of CK20 in this setting is low and this warrants replacement of this marker with SATB2 in clinical practice. 
700 1 |a Herpel, Esther  |d 1973-  |e VerfasserIn  |0 (DE-588)12965227X  |0 (DE-627)476593662  |0 (DE-576)297767984  |4 aut 
700 1 |a Sinn, Peter  |d 1957-  |e VerfasserIn  |0 (DE-588)1022590944  |0 (DE-627)717004783  |0 (DE-576)365646342  |4 aut 
700 1 |a Chang-Claude, Jenny  |e VerfasserIn  |0 (DE-588)1049304993  |0 (DE-627)781626188  |0 (DE-576)168344475  |4 aut 
773 0 8 |i Enthalten in  |t Modern pathology  |d London : Nature Publishing Group, 1988  |g 32(2019), 12, Seite 1834-1846  |h Online-Ressource  |w (DE-627)326643419  |w (DE-600)2041318-X  |w (DE-576)283165553  |x 1530-0285  |7 nnas  |a A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases 
773 1 8 |g volume:32  |g year:2019  |g number:12  |g pages:1834-1846  |g extent:13  |a A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases 
856 4 0 |u https://doi.org/10.1038/s41379-019-0302-0  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41379-019-0302-0  |x Verlag 
951 |a AR 
992 |a 20200124 
993 |a Article 
994 |a 2019 
998 |g 1049304993  |a Chang-Claude, Jenny  |m 1049304993:Chang-Claude, Jenny  |d 50000  |e 50000PC1049304993  |k 0/50000/  |p 59 
998 |g 1022590944  |a Sinn, Peter  |m 1022590944:Sinn, Peter  |d 910000  |d 912000  |e 910000PS1022590944  |e 912000PS1022590944  |k 0/910000/  |k 1/910000/912000/  |p 56 
998 |g 12965227X  |a Herpel, Esther  |m 12965227X:Herpel, Esther  |d 910000  |d 912000  |e 910000PH12965227X  |e 912000PH12965227X  |k 0/910000/  |k 1/910000/912000/  |p 11 
999 |a KXP-PPN1688466924  |e 3581393123 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Nicola S.","display":"Meagher, Nicola S.","family":"Meagher"},{"family":"Herpel","display":"Herpel, Esther","given":"Esther","role":"aut"},{"display":"Sinn, Peter","family":"Sinn","given":"Peter","role":"aut"},{"given":"Jenny","role":"aut","family":"Chang-Claude","display":"Chang-Claude, Jenny"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"25 June 2019"}],"note":["Gesehen am 24.01.2020"],"title":[{"title":"A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases","title_sort":"combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases"}],"id":{"eki":["1688466924"],"doi":["10.1038/s41379-019-0302-0"]},"name":{"displayForm":["Nicola S. Meagher, Linyuan Wang, Peter F. Rambau, Maria P. Intermaggio, David G. Huntsman, Lynne R. Wilkens, Mona A. El-Bahrawy, Roberta B. Ness, Kunle Odunsi, Helen Steed, Esther Herpel, Michael S. Anglesio, Bonnie Zhang, Neil Lambie, Anthony J. Swerdlow, Jan Lubiński, Robert A. Vierkant, Ellen L. Goode, Usha Menon, Aleksandra Toloczko-Grabarek, Oleg Oszurek, Sanela Bilic, Aline Talhouk, Montserrat García-Closas, Qin Wang, Adeline Tan, Rhonda Farrell, Catherine J. Kennedy, Mercedes Jimenez-Linan, Karin Sundfeldt, John L. Etter, Janusz Menkiszak, Marc T. Goodman, Paul Klonowski, Yee Leung, Stacey J. Winham, Kirsten B. Moysich, Sabine Behrens, Tomasz Kluz, Robert P. Edwards, Jacek Gronwald, Francesmary Modugno, Brenda Y. Hernandez, Christine Chow, Linda E. Kelemen, Gary L. Keeney, Michael E. Carney, Yanina Natanzon, Gregory Robertson, Raghwa Sharma, Simon A. Gayther, Jennifer Alsop, Hugh Luk, Chloe Karpinskyj, Ian Campbell, Peter Sinn, Aleksandra Gentry-Maharaj, Penny Coulson, Jenny Chang-Claude, Mitul Shah, Martin Widschwendter, Katrina Tang, Minouk J. Schoemaker, Jennifer M. Koziak, Linda S. Cook, James D. Brenton, Frances Daley, Björg Kristjansdottir, Constantina Mateoiu, Melissa C. Larson, Paul R. Harnett, Audrey Jung, Anna deFazio, Kylie L. Gorringe, Paul D.P. Pharoah, Parham Minoo, Colin Stewart, Oliver F. Bathe, Xianyong Gui, Paul Cohen, Susan J. Ramus, Martin Köbel"]},"physDesc":[{"extent":"13 S."}],"recId":"1688466924","relHost":[{"part":{"year":"2019","pages":"1834-1846","text":"32(2019), 12, Seite 1834-1846","issue":"12","volume":"32","extent":"13"},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesModern pathology","title":[{"title":"Modern pathology","subtitle":"an official journal of the United States and Canadian Academy of Pathology (USCAP)","title_sort":"Modern pathology"}],"note":["Gesehen am 05.01.23","Fortsetzung der Druck-Ausgabe"],"pubHistory":["1.1988 -"],"origin":[{"dateIssuedDisp":"1988-","dateIssuedKey":"1988","publisher":"Nature Publishing Group ; Lippincott Williams & Wilkins ; Ovid","publisherPlace":"London ; Hagerstown, Md. ; [Erscheinungsort nicht ermittelbar]"}],"id":{"eki":["326643419"],"zdb":["2041318-X"],"issn":["1530-0285"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"326643419"}]} 
SRT |a MEAGHERNICCOMBINATIO2520